Apotex Health to Raise Up to C$1.2 Billion in Toronto IPO
Canadian health company Apotex Health plans to raise up to C$1.2 billion through an initial public offering on the Toronto Stock Exchange, potentially signaling a revival of Canada's subdued IPO market. The offering includes new shares and existing shareholder sales.
Topics: capital raising IPO pharmaceuticals Toronto Stock Exchange